News Releases

Date Title and Summary View
Oct 10, 2018
Oct 09, 2018
Oct 04, 2018
Oct 02, 2018
Johnson & Johnson Completes Divestiture of LifeScan to Platinum Equity
NEW BRUNSWICK, N.J. , Oct. 2, 2018 /CNW/ --  Johnson & Johnson (NYSE: JNJ) today announced that it has completed the divestiture of its LifeScan business to Platinum Equity for approximately $2.1 billion . LifeScan, Inc. is a world leader in blood glucose monitoring and maker of the OneTouch ®
Sep 27, 2018
Janssen Elects Not to Continue Agreement with Geron for Imetelstat
Janssen Elects Not to Continue Agreement with Geron for Imetelstat HORSHAM, Pa., Sept. 27, 2018 /PRNewswire/ -- Janssen Biotech, Inc. (Janssen) announced today its decision not to continue the collaboration and license agreement with Geron Corporation for imetelstat.
Sep 26, 2018
Sep 21, 2018
Janssen Announces Results of Esketamine Nasal Spray Phase 3 Study in Patients with Treatment-Resistant Depression
TITUSVILLE, N.J. , Sept. 21, 2018 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced results from a Phase 3 clinical study of the investigational product esketamine nasal spray in patients with treatment-resistant depression.
Sep 19, 2018
Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results
NEW BRUNSWICK, N.J. , Sept. 19, 2018 /PRNewswire/ --  Johnson & Johnson (NYSE: JNJ) will host a conference call for investors at 8:30 a.m. (Eastern Time) on Tuesday, October 16 th , to review third-quarter results.  Joseph J. Wolk , Executive Vice President, Chief Financial Officer and Christopher
Sep 18, 2018
Sep 11, 2018
This site uses cookies as described in our Cookie Policy Please click the "Accept" button or continue to use our site if you agree to our use of cookies.